Pharma Pulse 6/12/25: The Antibody-Drug Conjugate Renaissance; Community Pharmacies Are Poised for a Transformative Role as Wellness Centers
The Antibody-Drug Conjugate Renaissance
A recent Pharmaceutical Executive article highlights how antibody-drug conjugates are experiencing a renaissance in oncology, with innovations in targeting, linker technology, and payload design driving broader applications, improved safety, and greater efficacy for patients with cancer.
Community Pharmacies Are Poised for a Transformative Role as Wellness Centers
Community pharmacies are evolving from traditional medication dispensers into vital community wellness centers by expanding services such as medication management, preventive screenings, nutrition support, and partnerships, positioning themselves as accessible, patient-centered health care hubs amid growing provider shortages and shifting toward value-based care.
New Insights On the Impact of AI-Enabled Solutions
An Applied Clinical Trials article reports that while AI-enabled solutions in drug development remain in early stages of adoption, growing regulatory support and empirical evidence show significant efficiency gains—such as reduced clinical trial cycle times and streamlined regulatory submissions—despite challenges around data trust, privacy, and intellectual property.
After Axing Diabetes Asset, Vertex Lays Off 140 Staff
Vertex Pharmaceuticals is laying off 140 employees after discontinuing its type 1 diabetes therapy VX-264, while navigating mixed financial results and challenges in its gene therapy efforts.
Former, Current CDC Employees Call on RFK Jr. to Resign
Current and former Centers for Disease Control and Prevention employees are urging HHS Secretary Robert F. Kennedy Jr. to resign, warning that his job cuts, funding reductions, and removal of the vaccine advisory panel are undermining the agency’s ability to protect public health and threatening vital programs.
